Department of Nuclear Medicine and Molecular Imaging, UZ Leuven, Leuven, Belgium
Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
J Nucl Med. 2020 Feb;61(2):256-262. doi: 10.2967/jnumed.119.228825. Epub 2019 Sep 3.
Animal models of alcohol dependence and relapse demonstrate an important role of the glutamatergic system, in particular, cerebral metabotropic glutamate receptor 5 (mGluR5). F-3-fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile (F-FPEB) PET has revealed that chronic alcohol use leads to decreased limbic mGluR5 availability, which was associated with less craving. Here, we tested whether the state of decreased mGluR5 availability in alcohol-dependent patients normalizes during abstinence (at 2 and 6 mo of detoxification) and whether initial mGluR5 imaging parameters can predict individual relapse. F-FPEB scans were performed for 16 recently detoxified alcohol-dependent patients (baseline condition), 2 mo after detoxification ( = 10), and 6 mo after detoxification ( = 8); 32 age- and sex-matched controls were included for comparison. mGluR5 availability was quantified by the F-FPEB total distribution volume using both voxel-by-voxel and volume-of-interest analyses. During follow-up, craving was assessed using the Desire for Alcohol Questionnaire, and alcohol consumption was assessed using the timeline follow-back method and monitored by hair ethyl glucuronide analysis. During abstinence, alcohol-dependent patients showed sustained recovered mGluR5 availability in cortical and subcortical regions compared with the baseline, up to the levels observed in controls, after 6 mo in most areas except for the hippocampus, nucleus accumbens, and thalamus. Higher striatopallidal mGluR5 availability was observed at the baseline in patients who had a relapse during the 6-mo follow-up period (+25.1%). Also, normalization of striatal mGluR5 to control levels was associated with reduced craving ("desire and intention to drink" and "negative reinforcement"; = 0.72-0.94). Reduced cerebral mGluR5 availability in alcohol-dependent patients recovers during abstinence and is associated with reduced craving. Higher striatal mGluR5 availability in alcohol-dependent users may be associated with long-term relapse.
酒精依赖和复发的动物模型表明,谷氨酸能系统,特别是脑代谢型谷氨酸受体 5(mGluR5)起着重要作用。F-3-氟-5-[(吡啶-3-基)乙炔基]苯腈(F-FPEB)PET 显示,慢性酒精使用导致边缘 mGluR5 可用性降低,这与渴望减少有关。在这里,我们测试了酒精依赖患者在戒断期间(在解毒的第 2 和 6 个月)mGluR5 可用性的降低状态是否恢复正常,以及初始 mGluR5 成像参数是否可以预测个体复发。对 16 名最近戒断的酒精依赖患者(基线条件)、戒断后 2 个月(n = 10)和 6 个月(n = 8)进行了 F-FPEB 扫描;纳入 32 名年龄和性别匹配的对照者进行比较。使用体素和感兴趣区分析,通过 F-FPEB 总分布容积定量 mGluR5 可用性。在随访期间,使用酒精渴望问卷评估渴望程度,使用时间线回溯法评估酒精摄入量,并通过毛发乙基葡萄糖醛酸分析进行监测。在戒断期间,与基线相比,酒精依赖患者的皮质和皮质下区域的 mGluR5 可用性持续恢复,直到 6 个月后达到对照组的水平,除了海马体、伏隔核和丘脑外。在基线时,在 6 个月随访期间复发的患者的纹状体纹状体纹状体 mGluR5 可用性较高(增加 25.1%)。此外,纹状体 mGluR5 向对照水平的正常化与渴望减少有关(“饮酒欲望和意图”和“负强化”;r = 0.72-0.94)。酒精依赖患者的大脑 mGluR5 可用性在戒断期间恢复,与渴望减少有关。酒精依赖患者的纹状体 mGluR5 可用性较高可能与长期复发有关。